Menopause Treatment Market Is Expected To Reach A Valuation Of USD 3.3 Billion at a CAGR of 4.2% By 2023

Menopause Treatment Market Is Expected To Reach A Valuation Of USD 3.3 Billion at a CAGR of 4.2% By 2023

Menopause Treatment Market
Menopause Treatment Market Analysis By Key Players, Trends, Insights, Dynamics, Future Outlook, Applications and Segmentation, Forecast to 2023

Menopause Treatment Market Size, Growth and Analysis By Hormonal Treatment (Estrogen, Progesterone, Combination), Non-Hormonal Treatment (Anti-Depressants, Anti-Anxiety, Anti-Migraine), End-User (Hospitals & Clinics, Academia & Research) – Global Forecast Till 2023

The Global Menopause Treatment Market is expected to reach a valuation of USD 3.3 billion at a CAGR of 4.2% over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). Menopause is the natural stage in a woman’s life where her reproductive capabilities start to wane, leading to hormonal changes, further leading to physiological and psychological changes. This can cause several problems for women, including depression, anxiety, difficulties in getting sleep, joint pain and conditions, migraines, and hot flashes. These problems have slowly come under the spotlight in the healthcare sector as the global geriatric population has grown and become a major factor for the healthcare sector. Many geriatrics retain a strong financial independence and a high level of disposable income, which makes them important for the healthcare sector.

The increasing awareness about women’s health has also played into the menopause treatment market’s hands, as awareness regarding menstruation and the various complications associated with it has spilled into the menopause treatment market, leading to a growing understanding of the issues related to menopause and increasing will to cure the same. The growing geriatric population is likely to remain a major driver for the global menopause treatment market over the forecast period.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4579

The steady advancement in the development of hormonal drugs is likely to be a major driver for the menopause treatment market over the forecast period. As the genetic background of hormones has started to become clearer due to increasing research into genetics, the development of hormonal drugs has become more refined, making the drugs more capable and sophisticated in their ability to combat the respective issues. This has empowered the menopause treatment market to a strong degree in recent years and is likely to remain a major driver for the market over the forecast period.

Menopause Treatment Market Competitive Analysis:

Leading players in the global menopause treatment market include Teva Pharmaceutical Industries Ltd., Cipla Inc., Eli Lilly and Company, Emcure Pharmaceuticals Ltd., Allergan plc, Pfizer Inc., Novo Nordisk A/S, Novartis AG, and Merck & Co. Inc.

In August 2019, a new procedure was developed by ProFam, a UK-based IVF specialist, that claims to delay the onset of menopause by up to 20 years. This procedure could be crucial in limiting the impact of the physiological aftereffects of menopause.

In June 2019, a new study was released illustrating the effectiveness of cognitive behavioral therapy in treating the psychological symptoms of menopause. With awareness about the psychological effects of menopause increasing, this could become a major trend in the global menopause treatment market over the coming years.

Menopause Treatment Market Segmentation:

The global menopause treatment market is segmented on the basis of hormonal treatment, nonhormonal treatment, end use, and region.

By hormone, the global menopause treatment market is segmented into estrogen, progesterone, a combination of the two, and others. The estrogen segment holds the dominant share in the global menopause treatment market and is likely to retain the leading share over the forecast period due to the tried and tested efficacy of estrogen treatment in ameliorating the consequences of menopause.

By nonhormonal treatment, the global menopause treatment market is segmented into antidepressants, anti-anxiety medication, anti-migraine medication, and others. Cognitive behavioral therapy could also carve out an important share in the global menopause treatment market over the forecast period due to the growing awareness about its efficacy in treating the psychological consequences of menopause and its pill-free nature.

By end use, the global menopause treatment market is segmented into hospitals and clinics, academic and research, and others.

Menopause Treatment Market Regional Analysis:

North America and Europe are the leading regional markets for menopause treatment due to the widespread awareness about menopause treatment in the regions and the growing geriatric population. Asia Pacific is also likely to emerge as an important regional market for menopause treatment in the coming years due to the growing geriatric population in the region.

Check Discount at: https://www.marketresearchfuture.com/check-discount/4579

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/menopause-treatment-market-4579